← Back to Screener
OSR Holdings, Inc. Common Stock (OSRH)
Price$0.43
Value ScoreC
Growth ScoreF
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-20.40%
Price vs S&P 500 (4W)-36.55%
VGM Score31.93
Market Capitalization$15.29M
All Metrics
Book Value / Share (Quarterly)$3.46
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.16
Price vs S&P 500 (YTD)-33.71%
Gross Margin (TTM)22.24%
Net Profit Margin (TTM)-363.29%
EPS (TTM)$-0.36
10-Day Avg Trading Volume1.19M
EPS Excl Extra (TTM)$-0.36
EPS (Annual)$-0.92
ROI (Annual)-21.97%
Gross Margin (Annual)20.40%
Cash / Share (Quarterly)$0.09
Revenue Growth QoQ (YoY)-36.41%
ROA (Last FY)-10.52%
EBITD / Share (TTM)$-0.80
Operating Margin (TTM)-726.06%
Cash Flow / Share (Annual)$-1.02
P/B Ratio0.15x
P/B Ratio (Quarterly)0.19x
Net Income / Employee (Annual)$-818,700
EV / Revenue (TTM)7.09x
Net Interest Coverage (TTM)-64.31x
ROA (TTM)-5.41%
EPS Incl Extra (Annual)$-0.92
Current Ratio (Annual)0.16x
Quick Ratio (Quarterly)0.14x
3-Month Avg Trading Volume4.67M
52-Week Price Return-64.30%
Revenue / Employee (TTM)$119,500
P/S Ratio (Annual)5.26x
Asset Turnover (Annual)0.02x
52-Week High$1.79
EPS Excl Extra (Annual)$-0.92
26-Week Price Return-4.47%
Quick Ratio (Annual)0.15x
13-Week Price Return3.71%
Total Debt / Equity (Annual)0.06x
Current Ratio (Quarterly)0.16x
Enterprise Value$18.63M
Asset Turnover (TTM)0.01x
Revenue / Employee (Annual)$132,100
Pretax Margin (Annual)-994.16%
Cash / Share (Annual)$0.18
3-Month Return Std Dev168.61%
Net Income / Employee (TTM)$-434,100
ROE (Last FY)-23.20%
Net Interest Coverage (Annual)-47.23x
EPS Basic Excl Extra (Annual)$-0.92
Total Debt / Equity (Quarterly)0.05x
EPS Incl Extra (TTM)$-0.36
ROI (TTM)-10.47%
P/S Ratio (TTM)5.82x
Revenue / Share (Annual)$0.15
Price vs S&P 500 (52W)-92.50%
Year-to-Date Return-22.78%
5-Day Price Return-13.23%
EPS Normalized (Annual)$-0.92
ROA (5Y Avg)-3.71%
Net Profit Margin (Annual)-619.82%
Month-to-Date Return-38.03%
EBITD / Share (Annual)$-0.94
Operating Margin (Annual)-631.01%
LT Debt / Equity (Annual)0.00x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.36
P/B Ratio (Annual)0.19x
Inventory Turnover (TTM)3.41x
Pretax Margin (TTM)-814.69%
Book Value / Share (Annual)$66.45
Price vs S&P 500 (13W)-6.03%
Beta0.62x
Revenue / Share (TTM)$0.08
ROE (TTM)-11.00%
52-Week Low$0.38
vGradeC
gGradeF
mGradeD
vgmGradeD
Show chart for
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.14
4.14
4.14
4.14
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
OSRHOSR Holdings, Inc. Common Stock | C | F | D | $0.43 |
| SYKStryker Corporation | C | C | D | $299.46 |
| MMM3M Company | C | F | C | $150.93 |
| BSXBoston Scientific Corp. | C | B | F | $47.98 |
| MDLNMedline Inc. Class A common stock | C | D | D | $35.75 |
| BDXBecton, Dickinson and Co. | B | C | C | $145.33 |
| DXCMDexCom, Inc. | C | B | C | $74.87 |
| RMDResMed Inc. | B | B | D | $186.44 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $316.30 |
| SOLVSolventum Corporation | C | D | C | $75.84 |
| PENPenumbra, Inc. | F | C | C | $318.95 |
About
OSR Holdings Inc operates in three healthcare segments: oral immunotherapy development for cancer, design-augmented biologics for age-related and degenerative diseases, and neurovascular medical device distribution in Korea. The company develops and commercializes therapeutic and medical device solutions to improve patient outcomes.